Host: Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP Patients presenting to the hospital with severe bleeding and underlying treatment with Factor Xa (FXa) or Factor IIa inhibitors represent an enormous challenge to providers and clinician

Host: Natalie Kreitzer, MD, MS Patients presenting to the hospital with severe bleeding and underlying treatment with Factor Xa (FXa) or Factor IIa inhibitors represent an enormous challenge to providers and clinicians since the approvals of api

Guest: Kenneth Alexander, MD, PhD Guest: Noel T. Brewer, PhD Healthcare providers face challenges in promoting HPV vaccination, which is now recommended for children at age 9. The good news is that there are scientifically validated, effecti

Host: James Galvin, MD, MPH, FANA Guest: Jon Toledo, MD, PhD Recently, Alzheimers Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (A) targeting DMT now a reality, the entire way this condition is

Host: Harry Paul Erba, MD, PhD Guest: Courtney DiNardo, MD Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Immuno-oncologic agents have changed the treatment landscape for non-small cell lung cancer. Listen as Drs.

Host: Joseph Mikhael, MD Guest: Monique Hartley-Brown, MD Guest: Brandon Blue, MD Multiple myeloma (MM) is the most common hematologic malignancy among African Americans, so its important that healthcare providers are aware of the dispa

Host: Sara A. Hurvitz, MD, FACP Host: Sara M. Tolaney MD, MPH This program provides education to help clinicians confidently diagnose and make informed clinical decisions with their patients, ultimately enhancing clinical outcomes in the evo

Host: Sara A. Hurvitz, MD, FACP This program provides education to help clinicians confidently diagnose and make informed clinical decisions with their patients, ultimately enhancing clinical outcomes in the evolving treatment landscape of ADCs

Host: Sara A. Hurvitz, MD, FACP This program provides education to help clinicians confidently diagnose and make informed clinical decisions with their patients, ultimately enhancing clinical outcomes in the evolving treatment landscape of ADCs

Host: Sara A. Hurvitz, MD, FACP Host: Sara M. Tolaney MD, MPH This program provides education to help clinicians confidently diagnose and make informed clinical decisions with their patients, ultimately enhancing clinical outcomes in the evo